Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'GENE LEADS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 54 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Abraham, EH; Sterling, KM; Kim, RJ; Salikhova, AY; Huffman, HB; Crockett, MA; Johnston, N; Parker, HW; Boyle, WE; Hartov, A; Demidenko, E; Efird, J; Kahn, J; Grubman, SA; Jefferson, DM; Robson, SC; Thakar, JH; Lorico, A; Rappa, G; Sartorelli, AC; Okunieff, P
      Erythrocyte membrane ATP binding cassette (ABC) proteins: MRP1 and CFTR aswell as CD39 (ecto-apyrase) involved in RBC ATP transport and elevated blood plasma ATP of cystic fibrosis

      BLOOD CELLS MOLECULES AND DISEASES
    2. Kondratov, RV; Komarov, PG; Becker, Y; Ewenson, A; Gudkov, AV
      Small molecules that dramatically alter multidrug resistance phenotype by modulating the substrate specificity of P-glycoprotein

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    3. Luker, GD; Dahlheimer, JL; Ostlund, RE; Piwnica-Worms, D
      Decreased hepatic accumulation and enhanced esterification of cholesterol in mice deficient in mdr1a and mdr1b P-glycoproteins

      JOURNAL OF LIPID RESEARCH
    4. More, MI; Kirsch, FP; Rathjen, FG
      Targeted ablation of NrCAM or ankyrin-B results in disorganized lens fibers leading to cataract formation

      JOURNAL OF CELL BIOLOGY
    5. Johnson, DR; Finch, RA; Lin, ZP; Zeiss, CJ; Sartorelli, AC
      The pharmacological phenotype of combined multidrug-resistance mdr1a/1b- and mrp1-deficient mice

      CANCER RESEARCH
    6. Diaz, GJ
      Basolateral and canalicular transport of xenobiotics in the hepatocyte: A review

      CYTOTECHNOLOGY
    7. Karaplis, AC
      Metabolic bone disease: Lessons from knockout mice

      DRUG DEVELOPMENT RESEARCH
    8. Rappa, G; Murren, JR; Johnson, LM; Lorico, A; Sartorelli, AC
      Novobiocin-induced VP-16 accumulation and MRP expression in human leukemiaand ovarian carcinoma cells

      ANTI-CANCER DRUG DESIGN
    9. Tanigawara, Y
      Role of P-glycoprotein in drug disposition

      THERAPEUTIC DRUG MONITORING
    10. van Asperen, J; van Tellingen, O; Beijnen, JH
      The role of MDR1A P-glycoprotein in the biliary and intestinal secretion of doxorubicin and vinblastine in mice

      DRUG METABOLISM AND DISPOSITION
    11. Chien, KR
      Genomic circuits and the integrative biology of cardiac diseases

      NATURE
    12. Wijnholds, J; de Lange, ECM; Scheffer, GL; van den Berg, DJ; Mol, CAAM; van der Valk, M; Schinkel, AH; Scheper, RJ; Breimer, DD; Borst, P
      Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier

      JOURNAL OF CLINICAL INVESTIGATION
    13. Pu, WT; Wickman, K; Clapham, DE
      ICln is essential for cellular and early embryonic viability

      JOURNAL OF BIOLOGICAL CHEMISTRY
    14. Allen, JD; Brinkhuis, RF; van Deemter, L; Wijnholds, J; Schinkel, AH
      Extensive contribution of the multidrug transporters P-glycoprotein and Mrp1 to basal drug resistance

      CANCER RESEARCH
    15. Daoud, R; Desneves, J; Deady, LW; Tilley, L; Scheper, RJ; Gros, P; Georges, E
      The multidrug resistance protein is photoaffinity labeled by a quinoline-based drug at multiple sites

      BIOCHEMISTRY
    16. Riley, J; Styles, J; Verschoyle, RD; Stanley, LA; White, INH; Gant, TW
      Association of tamoxifen biliary excretion rate with prior tamoxifen exposure and increased mdr1b expression

      BIOCHEMICAL PHARMACOLOGY
    17. Vezmar, M; Georges, E
      Reversal of MRP-mediated doxorubicin resistance with quinoline-based drugs

      BIOCHEMICAL PHARMACOLOGY
    18. Tessner, TG; Stenson, WF
      Overexpression of MDR1 in an intestinal cell line results in increased cholesterol uptake from micelles

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    19. Bradshaw, DM; Arceci, RJ
      Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance (vol 16, pg 3674, 1998)

      JOURNAL OF CLINICAL ONCOLOGY
    20. Vogelbein, WK; Fournie, JW; Cooper, PS; Van Veld, PA
      Hepatoblastomas in the mummichog, Fundulus heteroclitus (L.), from a creosote-contaminated environment: a histologic, ultrastructural and immunohistochemical study

      JOURNAL OF FISH DISEASES
    21. Koipally, J; Kim, J; Jones, B; Jackson, A; Avitahl, N; Winandy, S; Trevisan, M; Nichogiannopoulou, A; Kelley, C; Georgopoulos, K
      Ikaros chromatin remodeling complexes in the control of differentiation ofthe hemo-lymphoid system

      COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY
    22. Rao, VV; Dahlheimer, JL; Bardgett, ME; Snyder, AZ; Finch, RA; Sartorelli, AC; Piwnica-Worms, D
      Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    23. Frijters, CMG; Tuijn, CJ; Ottenhoff, R; Zegers, BN; Groen, AK; Elferink, RPJO
      The role of different P-glycoproteins in hepatobiliary secretion of fluorescently labeled short-chain phospholipids

      JOURNAL OF LIPID RESEARCH
    24. Nichogiannopoulou, A; Trevisan, M; Neben, S; Friedrich, C; Georgopoulos, K
      Defects in hemopoietic stem cell activity in Ikaros mutant mice

      JOURNAL OF EXPERIMENTAL MEDICINE
    25. Raggers, RJ; van Helvoort, A; Evers, R; van Meer, G
      The human multidrug resistance protein MRP1 translocates sphingolipid analogs across the plasma membrane

      JOURNAL OF CELL SCIENCE
    26. STEIN WD
      KINETICS OF THE P-GLYCOPROTEIN, THE MULTIDRUG TRANSPORTER

      Experimental physiology
    27. PREISS R
      P-GLYCOPROTEIN AND RELATED TRANSPORTERS

      International journal of clinical pharmacology and therapeutics
    28. TRAUNER M
      MOLECULAR ALTERATIONS OF CANALICULAR TRANSPORT-SYSTEMS IN EXPERIMENTAL-MODELS OF CHOLESTASIS - POSSIBLE FUNCTIONAL CORRELATIONS

      The Yale journal of biology & medicine
    29. SMYTH MJ; KRASOVSKIS E; SUTTON VR; JOHNSTONE RW
      THE DRUG EFFLUX PROTEIN, P-GLYCOPROTEIN, ADDITIONALLY PROTECTS DRUG-RESISTANT TUMOR-CELLS FROM MULTIPLE FORMS OF CASPASE-DEPENDENT APOPTOSIS

      Proceedings of the National Academy of Sciences of the United Statesof America
    30. WIJNHOLDS J; SCHEFFER GL; VANDERVALK M; VANDERVALK P; BEIJNEN JH; SCHEPER RJ; BORST P
      MULTIDRUG-RESISTANCE PROTEIN-1 PROTECTS THE OROPHARYNGEAL MUCOSAL LAYER AND THE TESTICULAR TUBULES AGAINST DRUG-INDUCED DAMAGE

      The Journal of experimental medicine
    31. KIM MJ; COOPER DD; HAYES SF; SPANGRUDE GJ
      RHODAMINE-123 STAINING IN HEMATOPOIETIC STEM-CELLS OF YOUNG MICE INDICATES MITOCHONDRIAL ACTIVATION RATHER THAN DYE EFFLUX

      Blood
    32. VANVEEN HW; KONINGS WN
      THE ABC FAMILY OF MULTIDRUG TRANSPORTERS IN MICROORGANISMS

      Biochimica et biophysica acta. Bioenergetics
    33. VANVEEN HW; KONINGS WN
      DRUG EFFLUX PROTEINS IN MULTIDRUG-RESISTANT BACTERIA

      Biological chemistry
    34. WIJNHOLDS J; EVERS R; VANLEUSDEN MR; MOL CAAM; ZAMAN GJR; MAYER U; BEIJNEN JH; VANDERVALK M; KRIMPENFORT P; BORST P
      INCREASED SENSITIVITY TO ANTICANCER DRUGS AND DECREASED INFLAMMATORY RESPONSE IN MICE LACKING THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN

      Nature medicine
    35. VANVEEN HW; KONINGS WN
      MULTIDRUG TRANSPORTERS FROM BACTERIA TO MAN - SIMILARITIES IN STRUCTURE AND FUNCTION

      Seminars in cancer biology
    36. LING V
      MULTIDRUG-RESISTANCE - MOLECULAR MECHANISMS AND CLINICAL RELEVANCE

      Cancer chemotherapy and pharmacology
    37. BEAULIEU E; DEMEULE M; GHITESCU L; BELIVEAU R
      P-GLYCOPROTEIN IS STRONGLY EXPRESSED IN THE LUMINAL MEMBRANES OF THE ENDOTHELIUM OF BLOOD-VESSELS IN THE BRAIN

      Biochemical journal
    38. GIANNI L
      ANTHRACYCLINE RESISTANCE - THE PROBLEM AND ITS CURRENT DEFINITION

      Seminars in oncology
    39. BAIN LJ; MCLACHLAN JB; LEBLANC GA
      STRUCTURE-ACTIVITY-RELATIONSHIPS FOR XENOBIOTIC TRANSPORT SUBSTRATES AND INHIBITORY LIGANDS OF P-GLYCOPROTEIN

      Environmental health perspectives
    40. ARBOIX M; PAZ OG; COLOMBO T; DINCALCI M
      MULTIDRUG RESISTANCE-REVERSING AGENTS INCREASE VINBLASTINE DISTRIBUTION IN NORMAL-TISSUES EXPRESSING THE P-GLYCOPROTEIN BUT DO NOT ENHANCE DRUG PENETRATION IN BRAIN AND TESTIS

      The Journal of pharmacology and experimental therapeutics
    41. DEBRY P; NASH EA; NEKLASON DW; METHERALL JE
      ROLE OF MULTIDRUG-RESISTANCE P-GLYCOPROTEINS IN CHOLESTEROL ESTERIFICATION

      The Journal of biological chemistry
    42. LUKER GD; RAO VV; CRANKSHAW CL; DAHLHEIMER J; PIWNICAWORMS D
      CHARACTERIZATION OF PHOSPHINE COMPLEXES OF TECHNETIUM(III) AS TRANSPORT SUBSTRATES OF THE MULTIDRUG-RESISTANCE P-GLYCOPROTEIN AND FUNCTIONAL MARKERS OF P-GLYCOPROTEIN AT THE BLOOD-BRAIN-BARRIER

      Biochemistry
    43. POULIOT JF; LHEUREUX F; LIU Z; PRICHARD RK; GEORGES E
      REVERSAL OF P-GLYCOPROTEIN-ASSOCIATED MULTIDRUG-RESISTANCE BY IVERMECTIN

      Biochemical pharmacology
    44. COX D; WESSELS D; SOLL DR; HARTWIG J; CONDEELIS J
      REEXPRESSION OF ABP-120 RESCUES CYTOSKELETAL, MOTILITY, AND PHAGOCYTOSIS DEFECTS OF ABP-120(-) DICTYOSTELIUM MUTANTS

      Molecular biology of the cell
    45. WEHNER F; KINNE RKH; PETZINGER E
      SECOND INTERNATIONAL RINGBERG CONFERENCE - CELL BIOLOGY AND MOLECULAR-BASIS OF LIVER TRANSPORT

      Hepatology
    46. LEVEILLEWEBSTER CR
      THE PERILS OF P-GLYCOPROTEIN INHIBITION

      Hepatology
    47. SHAROM FJ; YU XH; DIDIODATO G; CHU JWK
      SYNTHETIC HYDROPHOBIC PEPTIDES ARE SUBSTRATES FOR P-GLYCOPROTEIN AND STIMULATE DRUG TRANSPORT

      Biochemical journal
    48. VALVERDE MA; BOND TD; HARDY SP; TAYLOR JC; HIGGINS CF; ALTAMIRANO J; ALVAREZLEEFMANS FJ
      THE MULTIDRUG-RESISTANCE P-GLYCOPROTEIN MODULATES CELL REGULATORY VOLUME DECREASE

      EMBO journal
    49. TAMAI I; TSUJI A
      DRUG-DELIVERY THROUGH THE BLOOD-BRAIN-BARRIER

      Advanced drug delivery reviews
    50. VANHELVOORT A; SMITH AJ; SPRONG H; FRITZSCHE I; SCHINKEL AH; BORST P; VANMEER G
      MDR1 P-GLYCOPROTEIN IS A LIPID TRANSLOCASE OF BROAD-SPECIFICITY, WHILE MDR3 P-GLYCOPROTEIN SPECIFICALLY TRANSLOCATES PHOSPHATIDYLCHOLINE

      Cell
    51. LIU Z; LHEUREUX F; POULIOT JF; HECKEL A; BAMBERGER U; GEORGES E
      BIBW22 BS, POTENT MULTIDRUG RESISTANCE-REVERSING AGENT, BINDS DIRECTLY TO P-GLYCOPROTEIN AND ACCUMULATES IN DRUG-RESISTANT CELLS

      Molecular pharmacology
    52. STEWART PA; BELIVEAU R; ROGERS KA
      CELLULAR-LOCALIZATION OF P-GLYCOPROTEIN IN BRAIN VERSUS GONADAL CAPILLARIES

      The Journal of histochemistry and cytochemistry
    53. HITT AL; HARTWIG JH; LUNA EJ
      PONTICULIN IS THE MAJOR HIGH-AFFINITY LINK BETWEEN THE PLASMA-MEMBRANE AND THE CORTICAL ACTIN NETWORK IN DICTYOSTELIUM

      The Journal of cell biology
    54. DEHOSTOS EL; BRADTKE B; LOTTSPEICH F; GERISCH G
      COACTOSIN, A 17 KDA F-ACTIN BINDING-PROTEIN FROM DICTYOSTELIUM-DISCOIDEUM

      Cell motility and the cytoskeleton


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 11/08/20 alle ore 15:59:34